SomaLogic expands agreement with Novo Nordisk to 2025

Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases BOULDER, Colo.  -- SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk. As part of the agreement, which now extends into the end of [...]

Illumina’s Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023. Mr. Thaysen's extensive [...]

Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group

SANTA CLARA, Calif. -- Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG). Binns previously served as vice president and general manager of the Spectroscopy and Vacuum division for LSAG. Binns replaces Jacob Thaysen who left the company effective today. “We’re [...]

WITec Rolls Out alphaCART

Research-grade Raman microspectroscopy goes mobile. Oxford Instruments WITec has introduced alphaCART, a portable research-grade confocal Raman system. alphaCART lets researchers bring the laboratory to the sample for on-site chemical characterization with all the speed, sensitivity, and resolution of WITec’s renowned stationary instruments. This novel instrument bundles a freely positionable, fiber-coupled Raman probe with a laser, [...]

Change in management at ALTANA’s BYK division

Dr. Jörg Hinnerwisch, so far Chief Technology Officer at BYK, assumes the role of Division President and joins ALTANA’s Executive Management Team Dr. Tammo Boinowitz shifts his focus to responsibilities within the ALTANA Management Board, a position he has held since the start of this year Head of the Paint Additives business line Dr. Stefan [...]

ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement

ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement License allows AlgenScribe to expand its research and development activities using CRISPR/Cas9. Dublin, Ireland and Nice, France, September 5: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with AlgenScribe SAS (‘AlgenScribe’). This is a non-exclusive licensing agreement granting AlgenScribe access to the [...]

Xylem Announces CEO Succession Aligned with Growth Strategy and Next Steps in Value Creation

Patrick Decker to retire from CEO position at the end of the year and remain employed as an advisor through March 2024 COO Matthew Pine to assume CEO position effective January 1, 2024 William Grogan appointed CFO, succeeding Sandra Rowland, effective October 1, 2023 Company reaffirms third-quarter and full-year 2023 guidance WASHINGTON --  Xylem Inc. [...]

PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker

EMERYVILLE, Calif. -- PhenomeX Inc. (Nasdaq: CELL) today announced that Bruker Corporation (Nasdaq: BRKR) has commenced, through its wholly owned subsidiary, Bird Mergersub Corporation, a cash tender offer to purchase all outstanding shares of common stock of PhenomeX for $1.00 per share. The tender offer is being made pursuant to the previously announced merger agreement between PhenomeX [...]

Reynolda Equity Partners Portfolio Company ATG Acquires Technical Alternatives

Analytical Technologies Group, LLC (“ATG”), a portfolio company of Reynolda Equity Partners, is pleased to announce it has completed the acquisition of Technical Alternatives ("TA"), a provider of laboratory equipment repairs, preventative maintenance, replacement parts, and calibrations. The acquisition was made in partnership with founders David Westfall and Kirby Barnes. Founded in 1995 and based [...]

GenNext & SCIEX to Co-Market an Advanced High Order Structure Analysis (HOS) Workflow for Biopharmaceutical Research

Together, the companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics Caption: GenNext & SCIEX Co-Market High Order Structure Analysis (HOS) Workflow Half Moon Bay, CA –  GenNext Technologies, Inc., provider of novel instrumentation, software, and services for structural biology [...]

Access IBO on Knowledge Center